as 12-20-2024 3:40pm EST
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
Founded: | 2003 | Country: | United States |
Employees: | N/A | City: | SAN JOSE |
Market Cap: | 44.0M | IPO Year: | 2020 |
Target Price: | $4.38 | AVG Volume (30 days): | 809.6K |
Analyst Decision: | Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.75 | EPS Growth: | N/A |
52 Week Low/High: | $0.43 - $5.88 | Next Earning Date: | 02-19-2025 |
Revenue: | $114,729,000 | Revenue Growth: | -13.00% |
Revenue Growth (this year): | -11.42% | Revenue Growth (next year): | 10.83% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Nash Marc | OM | SVP Operations and R&D | Nov 15 '24 | Sell | $0.80 | 1,375 | $1,100.00 | 238,022 | |
Ahmed Nabeel | OM | Chief Financial Officer | Nov 15 '24 | Sell | $0.80 | 4,221 | $3,376.80 | 310,767 | |
Trigg Leslie | OM | Chair and CEO | Nov 15 '24 | Sell | $0.80 | 5,645 | $4,516.00 | 904,851 | |
Brottem John L. | OM | General Counsel | Nov 15 '24 | Sell | $0.80 | 3,203 | $2,562.40 | 227,092 |
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Insider Monkey
a month ago
Simply Wall St.
a month ago
GuruFocus.com
a month ago
Zacks
2 months ago
GlobeNewswire
2 months ago
GuruFocus.com
2 months ago
GlobeNewswire
2 months ago
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.